Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at the EASL congress on liver diseases, both showing promising results in metabolic dysfunction-associated steatohepatitis (MASH).

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term efficacy ...

Which are the best LoL champions for beginners? Understanding who is easy to play is half the battle if you want to find success early in your League of Legends career. The Summoner's Rift map can be ...

Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated history of working in both institutional and retail environments, from broker-dealers to ...

Enter System Settings from your Switch Home Menu. Scroll down to Data Management. Scroll down to the very bottom to Delete ...